Al Borg Diagnostics
We are always striving to the best
Al Borg Diagnostics Accreditations
Our Focus on quality is our number one priority in Al Borg Diagnostics, we do every effort to provide our customers with the highest quality products and services available. We are continuously improving our services in order to always meet their requirements.
Our quality management program, laboratory safety plan, electronic document control plan, and competency assessment program are among the best in the region. Currently, three of our laboratories are accredited by College of American Pathologists (CAP). The CAP's Laboratory Accreditation Program accredits the entire spectrum of laboratory test disciplines with the most scientifically rigorous customized checklist requirements.
Seven of our labs are accredited by the Joint Commission International (JCI)- Clinical laboratory program. JCI accreditation is considered the gold standard in global health care. Also two of our labs are ISO 15189 accredited.
Our plan is to have all our laboratories accredited within 3 years to ensure practicing the highest level of Quality and Patient safety.
Saudi Accreditation Committee (SAC)
Members of The Global Diagnostics Network
GDN members are some of the world’s leading diagnostics companies from every continent, operating at the highest professional standards. Collectively, the GDN is present in countries with over 68% of the world’s population. Al Borg Diagnostics is one of the GDN founders.
Enhancing diagnostic insights to address worldwide health challenges and improve local patient care.
Healthcare systems around the world are designed for local service delivery, yet diagnostic innovations and discoveries are occurring daily around the globe. These breakthroughs can remain localized and unshared.
The Global Diagnostics Network (GDN) is a strategic working group of diagnostic laboratories, each committed to unleashing and sharing local innovation to increase global access to diagnostic science and services — ultimately generating diagnostic insights and improving global healthcare.